Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
44.40
-0.60 (-1.33%)
Jan 21, 2026, 1:33 PM CET
-3.06%
Market Cap826.00M
Revenue (ttm)373.90M
Net Income (ttm)-2.89M
Shares Out18.36M
EPS (ttm)-0.16
PE Ration/a
Forward PE51.72
Dividendn/a
Ex-Dividend Daten/a
Volume7,852
Average Volume30,599
Open45.10
Previous Close45.00
Day's Range44.40 - 45.10
52-Week Range26.50 - 50.80
Beta-0.03
RSI51.34
Earnings DateMar 27, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.